Novo Nordisk

Novo Nordisk Pharma develops, imports, manufactures, and sells prescription pharmaceuticals and medical devices in Japan, with products including insulin preparations and growth hormone preparations. It is headquartered at the Meiji Yasuda Life Building in Marunouchi, Chiyoda-ku, Tokyo, and its shares are held by Novo Nordisk Region Japan & Korea.